Susquehanna International Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $81M | Sell |
495,300
-354,300
| -42% | -$54.5M | 0.01% | 959 |
|
|
2025
Q4 | $148M | Buy |
849,600
+1,200
| +0.1% | +$219K | 0.02% | 663 |
|
|
2025
Q3 | $122M | Sell |
848,400
-153,200
| -15% | -$18.8M | 0.01% | 769 |
|
|
2025
Q2 | $101M | Buy |
1,001,600
+665,600
| +198% | +$50.9M | 0.01% | 750 |
|
|
2025
Q1 | $25.6M | Sell |
336,000
-1,000
| -0.3% | -$76.5K | ﹤0.01% | 1520 |
|
|
2024
Q4 | $23.3M | Sell |
337,000
-104,900
| -24% | -$7.55M | ﹤0.01% | 1738 |
|
|
2024
Q3 | $32.3M | Sell |
441,900
-188,400
| -30% | -$13.9M | 0.01% | 1413 |
|
|
2024
Q2 | $42.2M | Buy |
630,300
+567,200
| +899% | +$22M | 0.01% | 1097 |
|
|
2024
Q1 | $1.71M | Buy |
63,100
+46,500
| +280% | +$1.3M | ﹤0.01% | 5697 |
|
|
2023
Q4 | $514K | Sell |
16,600
-13,800
| -45% | -$358K | ﹤0.01% | 8603 |
|
|
2023
Q3 | $768K | Buy |
30,400
+16,000
| +111% | +$366K | ﹤0.01% | 7240 |
|
|
2023
Q2 | $304K | Buy |
14,400
+2,800
| +24% | +$53.1K | ﹤0.01% | 9411 |
|
|
2023
Q1 | $198K | Buy |
+11,600
| New | +$225K | ﹤0.01% | 10608 |
|
|
2022
Q4 | – | Sell |
-43,700
| Closed | -$941K | – | 13010 |
|
|
2022
Q3 | $941K | Buy |
43,700
+13,700
| +46% | +$328K | ﹤0.01% | 6788 |
|
|
2022
Q2 | $592K | Sell |
30,000
-7,900
| -21% | -$166K | ﹤0.01% | 7848 |
|
|
2022
Q1 | $891K | Buy |
37,900
+28,600
| +308% | +$665K | ﹤0.01% | 7414 |
|
|
2021
Q4 | $253K | Buy |
+9,300
| New | +$266K | ﹤0.01% | 10905 |
|
|
2021
Q2 | – | Sell |
-41,100
| Closed | -$1.4M | – | 12896 |
|
|
2021
Q1 | $1.4M | Buy |
41,100
+26,800
| +187% | +$1.02M | ﹤0.01% | 6837 |
|
|
2020
Q4 | $476K | Sell |
14,300
-42,100
| -75% | -$1.54M | ﹤0.01% | 8394 |
|
|
2020
Q3 | $1.81M | Sell |
56,400
-9,700
| -15% | -$279K | ﹤0.01% | 4809 |
|
|
2020
Q2 | $1.82M | Sell |
66,100
-40,900
| -38% | -$970K | ﹤0.01% | 4662 |
|
|
2020
Q1 | $1.72M | Sell |
107,000
-121,000
| -53% | -$2.87M | ﹤0.01% | 4245 |
|
|
2019
Q4 | $5.45M | Buy |
228,000
+92,700
| +69% | +$1.89M | ﹤0.01% | 2867 |
|
|
2019
Q3 | $2.39M | Sell |
135,300
-16,500
| -11% | -$319K | ﹤0.01% | 3864 |
|
|
2019
Q2 | $3.89M | Sell |
151,800
-145,100
| -49% | -$4.04M | ﹤0.01% | 3071 |
|
|
2019
Q1 | $8.63M | Buy |
296,900
+56,700
| +24% | +$1.47M | ﹤0.01% | 1879 |
|
|
2018
Q4 | $3.15M | Sell |
240,200
-141,400
| -37% | -$2.26M | ﹤0.01% | 2869 |
|
|
2018
Q3 | $7.72M | Buy |
381,600
+236,400
| +163% | +$5.34M | ﹤0.01% | 2185 |
|
|
2018
Q2 | $3.43M | Sell |
145,200
-56,500
| -28% | -$1.45M | ﹤0.01% | 3208 |
|
|
2018
Q1 | $4.54M | Buy |
201,700
+82,500
| +69% | +$2.17M | ﹤0.01% | 2667 |
|
|
2017
Q4 | $3.72M | Sell |
119,200
-427,500
| -78% | -$12.6M | ﹤0.01% | 2904 |
|
|
2017
Q3 | $17.1M | Buy |
546,700
+379,000
| +226% | +$7.22M | 0.01% | 1341 |
|
|
2017
Q2 | $2.88M | Buy |
167,700
+47,700
| +40% | +$815K | ﹤0.01% | 3237 |
|
|
2017
Q1 | $2.1M | Sell |
120,000
-46,400
| -28% | -$716K | ﹤0.01% | 3642 |
|
|
2016
Q4 | $2.2M | Buy |
166,400
+15,700
| +10% | +$214K | ﹤0.01% | 3873 |
|
|
2016
Q3 | $2.19M | Buy |
150,700
+2,300
| +2% | +$28.8K | ﹤0.01% | 3420 |
|
|
2016
Q2 | $1.46M | Sell |
148,400
-12,100
| -8% | -$141K | ﹤0.01% | 4117 |
|
|
2016
Q1 | $2.03M | Buy |
160,500
+9,800
| +7% | +$129K | ﹤0.01% | 3732 |
|
|
2015
Q4 | $2.73M | Sell |
150,700
-2,500
| -2% | -$44K | ﹤0.01% | 3469 |
|
|
2015
Q3 | $2.85M | Buy |
153,200
+65,900
| +75% | +$1.64M | ﹤0.01% | 3598 |
|
|
2015
Q2 | $2.13M | Buy |
87,300
+15,500
| +22% | +$352K | ﹤0.01% | 4585 |
|
|
2015
Q1 | $1.49M | Buy |
71,800
+6,300
| +10% | +$111K | ﹤0.01% | 4925 |
|
|
2014
Q4 | $1.01M | Sell |
65,500
-78,900
| -55% | -$1.12M | ﹤0.01% | 5856 |
|
|
2014
Q3 | $1.88M | Sell |
144,400
-258,500
| -64% | -$3.9M | ﹤0.01% | 4717 |
|
|
2014
Q2 | $8.05M | Buy |
402,900
+119,600
| +42% | +$1.77M | ﹤0.01% | 2386 |
|
|
2014
Q1 | $5.39M | Buy |
283,300
+157,000
| +124% | +$2.98M | ﹤0.01% | 2787 |
|
|
2013
Q4 | $2.15M | Buy |
126,300
+44,000
| +53% | +$674K | ﹤0.01% | 4147 |
|
|
2013
Q3 | $1.28M | Sell |
82,300
-155,400
| -65% | -$1.97M | ﹤0.01% | 4858 |
|
|
2013
Q2 | $2.84M | Buy |
+237,700
| New | +$2.43M | ﹤0.01% | 3346 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Susquehanna International Group's INSM Position: Q1 2026 in Review
Susquehanna International Group reduced its Insmed (INSM) stake by 7.9% in Q1 2026, selling an estimated $2.3M and leaving 173,630 shares worth $28.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1796.
Susquehanna International Group first reported a position in INSM in Q3 2013 and has held it in 40 quarters since. The position peaked at $34.2M in Q1 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Susquehanna International Group held 173,630 shares of Insmed worth $28.4M as of Q1 2026.
- Susquehanna International Group sold 14,946 Insmed shares in Q1 2026, an estimated $2.3M.
- Insmed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1796 holding.
- Susquehanna International Group first reported a position in Insmed in Q3 2013 and has held it in 40 quarters since.
- Susquehanna International Group's Insmed position peaked at $34.2M in Q1 2025.
- 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.